New Risk • May 29
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 27% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (€14.2m market cap, or US$16.5m). Board Change • May 08
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Non-Executive Independent Director Luc Boedt was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. New Risk • Apr 07
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€11.0m market cap, or US$12.6m). New Risk • Jan 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €19.9k (US$23.4k) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.7m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-€2.7m). Market cap is less than US$10m (€19.9k market cap, or US$23.4k). New Risk • Sep 26
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.38m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.7m free cash flow). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Negative equity (-€2.7m). Market cap is less than US$10m (€8.38m market cap, or US$9.80m). Announcement • Aug 21
Crescent NV to Report First Half, 2025 Results on Sep 19, 2025 Crescent NV announced that they will report first half, 2025 results on Sep 19, 2025 New Risk • May 05
New major risk - Negative shareholders equity The company has negative equity. Total equity: -€1.1m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.5m free cash flow). Share price has been highly volatile over the past 3 months (8.5% average weekly change). Negative equity (-€1.1m). Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.8m market cap, or US$14.5m). New Risk • Apr 08
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 2.3% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€12.8m market cap, or US$13.9m). New Risk • Nov 07
New major risk - Revenue and earnings growth Earnings have declined by 2.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 2.3% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€20.7m market cap, or US$22.3m). Board Change • May 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Director Paul Matthijs was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Announcement • Apr 26
Crescent NV to Report Fiscal Year 2023 Results on May 28, 2024 Crescent NV announced that they will report fiscal year 2023 results on May 28, 2024 New Risk • Jul 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 8.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (8.3% average weekly change). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (€39.1m market cap, or US$43.0m). Price Target Changed • Nov 16
Price target decreased to €0.03 Down from €0.04, the current price target is provided by 1 analyst. New target price is 78% above last closing price of €0.017. Stock is down 32% over the past year. The company posted a net loss per share of €0.003 last year. Price Target Changed • Apr 27
Price target decreased to €0.03 Down from €0.04, the current price target is provided by 1 analyst. New target price is 51% above last closing price of €0.02. Stock is down 38% over the past year. The company posted a net loss per share of €0.003 last year. Price Target Changed • Mar 31
Price target decreased to €0.03 Down from €0.04, the current price target is provided by 1 analyst. New target price is 46% above last closing price of €0.021. Stock is down 36% over the past year. The company posted a net loss per share of €0.003 last year. Reported Earnings • Oct 06
First half 2021 earnings released: €0.001 loss per share (vs €0.001 loss in 1H 2020) The company reported a poor first half result with increased losses, weaker revenues and weaker control over costs. First half 2021 results: Revenue: €7.89m (down 13% from 1H 2020). Net loss: €1.40m (loss widened 39% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 01
First half earnings released Over the last 12 months the company has reported total losses of €5.41m, largely unchanged from the prior year. Total revenue was €18.3m over the last 12 months, up 3.2% from the prior year.